Tools

Belgian pharmaceutical group UCB SA said a committee of the U.S. Food and Drug Administration voted in favor of… »   

Roche’s experimental leukaemia drug known as GA101 delayed disease progression in people with one of the most common forms of… »   

A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the… »   

U.S. health regulators need more time to review Merck & Co’s application to sell sugammadex, an injection designed to reverse… »   

The U.S. Food and Drug Administration approved a lung cancer drug made by Boehringer Ingelheim to treat patients who are… »   

Alnylam Pharmaceuticals Inc said an early-stage trial of its gene-based therapy showed the drug was effective in suppressing a protein… »   

Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in newly… »   

Swiss drugmaker Novartis’ eye drug Lucentis has been approved as a treatment for a further condition related to worsening eyesight… »   

Insmed Inc’s experimental lung infection drug fared no better than a competing drug developed by Novartis AG in a lung… »   

Merck & Co Inc said the U.S. Food and Drug Administration rejected the company’s experimental insomnia drug, citing safety issues.